Tybourne Capital Management Investor
Tybourne is a global investment firm with a fundamental approach to equity investing, both public and private
Industry:
Longevity Biomarkers
Acquisitions Number:
4
Number Of Exists:
7
Headquarters:
Hong Kong, Hong Kong Island, Hong Kong
Investor Type:
Hedge Fund, Private Equity Firm
Employee Number:
11-50
Investors Number:
21
Investment Stage:
Late Stage Venture, Post-Ipo, Private Equity
Founded Date:
2011-01-01